focal point of incredibleness

Dear Shareholders, 

Previous President of India, Late Dr. APJ Abdul Kalam regularly used to quote "You are never given a fantasy without the ability to make it work out". 

Dispatch of our ''focal point of incredibleness ''at Pune is reminiscent of our old affectionate recollections with Dr. Kalam. As we recall that him, we draw gigantic feeling of motivation and also desire. Motivation to remain against multifaceted difficulties as they rise and yearning to be an impactful pioneer in our part, while conquering all hindrances. 

Much sooner, Bilcare set up its worldwide foot shaped impressions in the created economy, it had a dream to be worldwide pioneer, and in doing as such, it sought after a fantasy that encapsulates Dr. Kalam's' thought. 

In numerous event, I had the chance to look for his instruct and favors wealth source with respect to inspiration, which thusly offered us in taking forward some of our development on medication some assistance with dispensing and ncID™ Technology. 

Bilcare dependably took a gander at pharma bundling from an investigative, research point, which not just offered us to be a pioneer in a few medication some assistance with dispensing advances additionally secured these developments with worldwide licenses, which thusly helped us to be on top of things, while making our blessing from heaven! 

Bilcare Research AG (BRAG), containing pharma, claim to fame and card bundling business in the US, Europe and now Asia, which constitute more than 80 % of Company's' aggregate income is ''Gaining Momentum'' to develop as key development driver for the Company, exhibiting solid turnover development and edge change in the ebb and flow year. Gloat's' Revenue has expanded from EUR 240 Mn. in (2011/12) to EUR 265 Mn. in (2014/15), current year, regardless of way out from bundling business worth EUR 40 Mn. Correspondingly, BRAG EBIDTA is up from EUR 8 Mn. in (2011/12) to EUR 27 Mn. in (2014/15) because of judicious technique execution, cost proficiency and realignment of business and items. 

Boast business having merged and collected authority position in the US and Europe, is presently hoping to grow and tap high potential Asian markets. Bilcare Research AG procured Bilcare Singapore pharma bundling resources and adjusted to its European and US plan of action as a characteristic strategy, furthermore to grow its client base in Mainland China, and other Asian markets, making Singapore as an Asian Hub. 

It is likewise conceivable to say that BRAG, a quickly leading so as to develop business is very much financed European saves money with stable reimbursement giving further driving force for development in deals and edges. 

As a major aspect of limit development plan to mix development and meet client prerequisite, BRAG is presently contributing 15 Million Euro at its assembling site Staufen, Germany, where Bilcare is been referred to for quite a long time as a solid and submitted accomplice in the therapist movies market. 

Our most recent two years abroad rebuilding exercise has launch to obvious result this year and this pattern should proceed in the following years. 

Bilcare keeps on contributing on R&D exercises and viably use its speculations made on formation of examination locales bringing about effective expansion of more up to date items, forms administrations and advances to its development portfolio. Amid the budgetary year, Bilcare documented 2 new Patent applications identified with its inventive items and advances and were allowed 9 Patents, before connected. 

Bilcare R&D got leap forward in growing light weight material that can have a great obstruction for ''Nuclear Radiation''. DRDO have taken their first model trial with this material and have put in a request for the same. 

Bilcare GCS timed 12.8% Revenue development with expansion of 14 new customers. ''Comparator Sourcing'' business expanded generously over a year ago, indicating 40% development. With development and expanding client necessity from the west, GCS opened showcasing workplaces in USA and UK to catch future open door. We anticipate that this business division will cross INR 100 Cr. by one year from now. 

Bilcare Technology made advances in stowing pharma and Government clients and critical pilot ventures. Discussing pharma, there was line incorporation venture for serialization administrations for essential, optional and tertiary level bundling for Biocon, including supply of auxiliary and tertiary marks. Additionally, we could execute serialization and track and follow according to DGFT and MoHFW command for optional and tertiary packs for Merck at Fulford India Ltd and Organ on India. 

An outlook change in Bilcare ncID Technology is relied upon to be unleashed with incitement of exceptionally capable technocrat; who alongside his ''new group'' is chipping away at go-to-the-business sector technique with client arranged arrangement offerings. 

Financials: 

Absolute Standalone Revenue for the year declined from INR 394.47 Cr. in (FY14) to INR 335.60 Cr. in (FY15). 

This loss of offers is basically by virtue of mash in working capital combined with misfortune/unfulfillment of requests, or as it were we needed to swear off requests close by because of crude material inaccessibility for said reasons. This brought about diminished EBIDTA of INR 25.29 Cr. in the present year, (FY15) from INR 57.49 Cr. of the earlier year, (FY14). 

Increment in deterioration from INR 67.81 Cr. in (FY14) to INR 105.52 Cr. in (FY15) brought about extra increment of INR 37.71 Cr. because of progress in Company's' demonstration 2013, bringing about Net Loss of INR 183.68 Cr. for the year, (FY15). 

Be that as it may, Revenue for the quarter finished, (Q4 FY15) remained at INR 90.48 Cr. as against INR 78.16 Cr. of the past quarter (Q3 FY15), demonstrating a development of 15.76% 

Complete Consolidated Revenue for the present year finished, (FY15) lessened to INR 2737.88 Cr. as against INR 3075.66 Cr. of the most recent year (FY14) with EBIDTA% insignificantly up from 8.35% to 8.44%. 

"Disappointment will never surpass me if my definition to succeed is sufficiently solid" this expression of Dr. Kalam is maybe most able, when I consider India Business. 

As you know, India Business in most recent two years in experiencing certain anxiety because of befuddle of money streams affecting crude material acquirement and meeting clients'' orders close by, subsequently our top and main concern has endured to a vast degree. 

We have strived difficult to meet our leaser duty – with just about 60% determination of obligation through different choices and structures admissible under managing an account system. We are sure to pivot headwinds, through our ceaseless, aggregate, antagonistic try, investigating every single conceivable alternative. 

With BRAG business hinting at obvious energy, close by India obligation under expedient determination, I am sure that your Company will soon turn out from avenue of its turbulent past to a superior and brilliant future in the coming monetary year. 

As I close, might I, in the interest of your Board of Directors and the workers of your Company, at the end of the day thank you for your proceeded with backing and support. 

Much thanks to you, Ladies and Gentlemen. 

Mohan H. Bhandari 

Administrator and Managing Director

Bilcare: Main concern for the Pharma Packaging Innovation and solutions

Developing new evolution markets poses yet another challenge. Especially, however, the pharmaceutical industry must keep patients’ needs in mind. This means new routes must be taken and sustainable packaging innovation solutions  are in demand for the linctus of the future. In addition to the medications themselves, pharma packaging innovation also requires special know-how. Ensuring the best possible safety for these highly sensitive products calls for manufacturers with ideas. Due to growing  imports and exports of drugs.

However,  “quality management varies from country to country,” notes Sarah Russell from the Health Systems and Services Department of the World Health Organization (WHO) in describing one of the major challenges that this development poses. If a drug isn’t packaged properly, even the best active ingredient will be of no help. For this reason, the Center for Drug Evaluation and Research of the American Food and Drug Administration, or FDA for short, has included packaging in the drug registration process. As the FDA puts it. We can’t meet the expense to allow packaging innovation solution to become the weakest link in the global pharmaceutical chain.

Bilcare has been meeting these necessities for quite some time already and manufactures one of the highest quality dedicated glasses for pharmaceutical packaging in the same eminence at four different sites all over the world. Special glass tubing that has been on the market for century has been improved for use in pharma packaging and is known for its high chemical resistance. It can be treated quite easily and features outstanding barrier characteristics for medications that guard them from being vulnerable to oxygen. Because of its low alkali content and optional UV resistance, it permits the medication to hold its efficacy for many years. The exactly shaped glass tube also tends to repel breakage and scratches, an important feature for machine processing during mass production of these containers.

Pharma Packaging Innovations: Important Aspect of the Industries that by 2025

The pharmaceutical industry has been nearby for quite a long time, but it still leftovers one of the frontiers when it comes to packaging design. Pharma packaging design is naturally linked to how consumers see the product and as an outcome is one of the more important features of a pharmaceutical company’s marketing concerns. Pharma packaging innovation is a convoluted subject because labels on pharmaceuticals need to conform to certain FDA and EPA guidelines on what needs to be displayed and meet the terms with child resistant packaging requirements. Packaging as a whole is such an important aspect of the industry that by 2025, it is assessed that packaging will make up as much as two-thirds of the entire industry by market share.

Innovations in Pharma Packaging Design:

In recent tests, some pharmaceutical companies have admitted to thinking outside the box when it comes to their pharma packaging innovation and design.  One concept is that of a packaging design that, like a banana, tends to “go bad” as the expiration date of the medicine contained within approaches.  Other innovations include temperature protection, where a bottle will pay some sort of color warning if the place, it’s stored in is too hot or too cold, possibly even denature the product so that it is harmless if such a situation occurs.  The thinking in the pharmaceutical packaging departments around the world tend towards making innovative packaging that makes it easier to use the product in the best circumstances.  As time goes by, these innovations could make their way onto consumer shelves in great quantities.

Packaging and Patients:

Pharma packaging design is essential in a number of ways, but most importantly in how it affects the end user. The design is the point of contact between the treatment and the patient; proper packaging can embolden a user to keep up with his or her treatment. Hard-to-use packaging frightens users from consuming the product and this in turn means that there could be a much higher possibility of the patient foregoing their recommended treatment.

Request for proposals:

 (RPF) is usually put up by a pharmaceutical company having a drug product looking for a contract manufacturing site.  RPF includes all the information about the organization and time & cost involved. It is a crucial aspect that has a major effect on the relationship between the manufacturer and sponsor. The transfer of technology and the cost of commercial products can be adversely affected by a poorly organized RPF. It also has the potential to slow down the process of selecting the best manufacturer. Bilcare, a prominent name in the pharma packaging industry points out the important aspects an organization should ensure while developing a RPF.

Bilcare infusing Packaging Innovation Solutions

To make sure of people's health, the pharmaceutical industry is going through numerous changes which include drug research progress, generic production rise and upcoming trends in pharma packaging. Increase in population and increase in personal income, both contribute in high medicine and drug use. With the increasing need of medicines, the need to keep them safe, secure and sustainable, increases along. Pharma packaging leader, Bilcare is enumerating a few of the emerging trends in pharma packaging industry, which it follows and they are easy to infuse in ongoing packaging innovation solutions by any pharma packaging company, just like Bilcare. These trends are:

• Unit dose packaging: it is very important for the person on medication to intake the right amount of medicine. That is why unit dosage and single unit packaging is in the trend which contributes 11% in the annual growth of pharma packaging industry. It is one of the biggest growth drivers of the growth in the industry.

• Anti-counterfeiting packaging: the pharma packaging industry is facing the problem of counterfeiting on a large-scale, where many lives are at risk. To cope with this problem, pharma companies are adopting strategies like laser surface authentication, fluorescent labels, barcoding, holograms, watermarks, to name a few.

• Eco-friendly packaging: there is no lack of packaging innovation solutions which don’t address the environmental factors and concerns. It doesn’t lead to any kind of compromise with quality of a product or its accessibility.

• Child resistant packaging: today most of the medicines get packed while keeping children and senior citizens in mind. Child-resistant (CR) packaging and Senior Friendly (SF) packaging is the need of this hour, which pharma packaging specialists like Bilcare, are catering.

Bilcare is a global leader and an innovation-led packaging solutions provider that partners with the pharmaceutical industry to improve patient healthcare outcomes. It endeavors to deliver effective and affordable solutions that enhance the speed and quality of drug discovery and help build and protect brands by ensuring the delivery of genuine medicines to patients.

Packaging Innovation Trends and Solutions

Not much changes very often, or very quickly, in the world of  pharma packaging innovations  for clinical trials—but there are a few trends.

Protecting ‘The Blind,’ Maintaining Consistency

Although pharma packaging may seem simpler to produce because it is designed to look generic, certain aspects can be more difficult. It is critical for a clinical trial package to ‘protect the blind.’ Everything —from the positioning of any printed elements to the color—has to look exactly identical. Even slight variations are unacceptable.

The ‘Blinding’ Process

Typically, customers will send the supplier the products that will be used in a trial, and Bilcare works with customers to find design solutions. The pharma packaging is “blinded” by being redesigned and altered, to ensure that no one will be able to spot any differences. This is necessary when a trial is comparing the effectiveness of two different drugs. Often, a drug that is already approved and on the market is being compared to a new one.

Utilizing Technology to Increase Productivity

Bar codes, when used on clinical trial packaging, can be another way to “protect the blind.” Suppliers say they also help make the randomization process more efficient. Bilcare have more packaging solutions that often incorporates bar code printers, as well as track and trace capabilities, into machinery lines for customers using its automated equipment. They often prints 2-D bar codes on labels for products that will be sent to a trial. The codes contain randomization and blinding information. This leads to shorter production times, quality improvement, and cost reduction. There is an initial investment in hardware and software, but the long-term savings can be well worth it, especially for larger trials.

Utilizing the Blister to Increase Patient Compliance

Some suppliers say calendarized blisters have become much more popular for clinical trials. So these blisters help ensure the patient adheres to a specific dosing regimen. Generally, blisters are more compliant, especially if titration is involved or the patient needs to take two different products. A blister may also be dictated due to the stability of a drug.

Electronic Solutions

Packages that electronically monitor patients’ dosing regimens have been around for more than 10 years and are only now slowly increasing in popularity. The market is beginning to develop. Electronic adherence packages are now being considered by drug developers as a tool to collect data. In most cases, the data captured is the date and time patients remove medicine from the package. A bottle cap, with a built-in timer, is one type of electronic monitoring system.

Responsibilities Shift in the Future 

Pharma companies are outsourcing many new types of jobs lately, which have traditionally been done internally. Bilcare  is one supplier that has been taking on additional responsibilities that have included managing the entire supply chain.

Interphex focuses on the concepts of Packaging innovation

Interphex, the annual pharmaceutical manufacturing and packaging show was held on April 2010 at the Jacob K. Javits Convention Center in New York City. The event highlighted the need & importance of pharmaceutical, biopharmaceutical, and medical devices and will be attended by various renowned innovative packaging solution providers like Bilcare and several other manufacturers. It was followed by a conference providing comprehensive educational opportunities to bring forth the trending concepts of Pharma Packaging and challenges faced by the pharmaceutical and biopharmaceutical experts. There were around 70 sessions and workshops covering various aspects of pharma Packaging Innovation Solutions providing significant knowledge about it.

The event included a one-on-one meeting with the Pharma Packaging experts and technical professionals of the industry who provided information and guidelines to the pharmaceutical and biotechnology industry manufactures through live demonstrations.  They acquainted the manufacturers about the innovative packaging concepts along with the latest products and equipment. The manufacturers were provided expert advice by the professionals to face specific challenges in the Pharma Packaging sector. The event focused on the need for packaging innovation solution and covered the ways to find new resources and source new products. All the aspects and concepts of drug manufacturing and Pharma packaging from the stage of process development to delivery in markets were covered with complete knowledge and technological solutions to the manufacturers by the experts. The event highlighted all the fundamentals of life sciences manufacturing and the changing or up-coming trends like Automatic Systems, Child-Resistant Packaging, Anti- counterfeiting OVD, Vial Labeler, Self-Lifting Label etc. in the industry.

Medicine Packaging Innovation Firms

Medicine packaging innovation is a vital component of the medicine delivery system as pharmaceutical companies have to be extremely careful that their drugs reach the end user in a sterile and usable condition. The packaging has to meet stringent FDA standards, be suitable for the contents and also be easy to transport and keep on shelves, be antiseptic, tamper proof, have childproof caps at the same time being senior friendly. When  medicines have to be used in a hospital or institutional environment, they may require different packaging than when they are used by a retail customer. Medicine packaging is used by pharmaceutical companies

Pharmaceutical companies manufacture a wide range of medicine with different delivery systems including:

· Ingestible liquids

· Sprays

· Drops

· Creams, ointments and gels

· Tablets

· Gel caps

· Dispensers

Often specific medicine need very special packaging innovations – sometimes doses have to be marked, sometimes medicines have to be available in a single dose, disposable container. Other times drugs have to be dispensed in particular quantities in containers that are safe for long-term use.

Medicine packaging has to be done in impermeable containers that are strong enough to keep the contents safe during handling and transport. The product should be safe from adulteration, biological contamination or physical damage. Containers may be available in:

· Glass

· PVC

· PET

· Polycarbonate

· Polypropylene

· LDPE

· HDPE

· Polystyrene

With advances in technology and packaging materials, you can get the right packaging for your drugs that are safe, meets all the regulatory standards and is attractive.

If you need the proper packaging for your pharmaceutical products, you have come to the right place. Bilcare can easily source what you need and even suggest the correct packaging solutions for your medicine. You can design special packaging containers for your products as well and our design team is always ready to help you. What's more, we offer the best rates and friendly services – once you come to us, you will never go anywhere else.